Gene interactions and pathways from curated databases and text-mining

◀ Back to AKT1

AKT1 — AR

Pathways - manually collected, often from reviews:

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

Text-mined interactions from Literome

Solit et al., Clin Cancer Res 2002 (Prostatic Neoplasms) : Because mutations in the androgen receptor (AR) and activation of HER2 and Akt may account, in part, for prostate cancer progression after castration or treatment with antiandrogens, we sought to determine whether an inhibitor of Hsp90 function could degrade these Hsp90 client proteins and inhibit the growth of prostate cancer xenografts with an acceptable therapeutic index
Kang et al., J Bone Miner Res 2004 : This suggests that nongenomic androgen activation of Akt is mediated by androgen receptor in osteoblasts
Ghosh et al., Endocr Relat Cancer 2005 (Neoplasms, Hormone-Dependent...) : Akt regulates the expression and activation of the androgen receptor
Lu et al., Int J Oncol 2006 (Prostatic Neoplasms) : The purpose of this study is to investigate the role of PI3K-Akt signaling in prostate cancer cell growth and androgen receptor (AR) mediated gene expression
Papadopoulou et al., Molecular cancer 2008 (Prostatic Neoplasms) : Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells
Hong et al., Exp Cell Res 2013 (MAP Kinase Signaling System...) : Our results also demonstrate that AKT regulates androgen receptor levels partly via the Raf/MEK/ERK pathway